Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Centre for Process Innovation
Centre for Process Innovation
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Pfizer partners with Medicines Manufacturing Innovation Centre
The company will be participating in the centre’s first ‘grand challenge,’ aiming to develop a continuous direct compression platform for oral solid dosage medicines
Research & Development
MicrofluidX makes key collaboration for microfluidics platform
CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the rapid scale-up of cell and gene therapies
CPI CEO passes the torch
Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar
Research & Development
CPI and Oxford University join forces to lower NADH production cost
A constant feed of the expensive cofactor NADH is a requirement in many biocatalytic reactions and this has hindered industrial adoption of the technology
Ingredients
Rapid formulation stability screening platform tests real-world use
Following two years of research by CPI at Imperial College London and the University of Durham, the project is now translating the academic work into real-world applications
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Manufacturing
Innovation centre works with pharma giants on continuous manufacturing
CPI and Strathclyde University’s strategic partnership with GSK and AstraZeneca has begun work on a continuous direct compression platform for oral solid dosage medicines
Subscribe now